194 related articles for article (PubMed ID: 35545048)
21. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
[TBL] [Abstract][Full Text] [Related]
27. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
28. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
29. Splicing factor SRSF3 represses translation of p21
Kim J; Park RY; Kee Y; Jeong S; Ohn T
Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491
[TBL] [Abstract][Full Text] [Related]
30. The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.
Taketo K; Konno M; Asai A; Koseki J; Toratani M; Satoh T; Doki Y; Mori M; Ishii H; Ogawa K
Int J Oncol; 2018 Feb; 52(2):621-629. PubMed ID: 29345285
[TBL] [Abstract][Full Text] [Related]
31. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification.
Yu Y; Zou YF; Hong RQ; Chen WJ; Chen L; Chen WQ; Wang HP; Yu Y
Kaohsiung J Med Sci; 2022 Oct; 38(10):981-991. PubMed ID: 36053032
[TBL] [Abstract][Full Text] [Related]
33. B7-H3 is spliced by SRSF3 in colorectal cancer.
Zhang C; Chen Y; Li F; Yang M; Meng F; Zhang Y; Chen W; Wang W
Cancer Immunol Immunother; 2021 Feb; 70(2):311-321. PubMed ID: 32719950
[TBL] [Abstract][Full Text] [Related]
34. m
Ninomiya K; Iwakiri J; Aly MK; Sakaguchi Y; Adachi S; Natsume T; Terai G; Asai K; Suzuki T; Hirose T
EMBO J; 2021 Aug; 40(15):e107976. PubMed ID: 34184765
[TBL] [Abstract][Full Text] [Related]
35. SRSF3 promotes pluripotency through
Ratnadiwakara M; Archer SK; Dent CI; Ruiz De Los Mozos I; Beilharz TH; Knaupp AS; Nefzger CM; Polo JM; Anko ML
Elife; 2018 May; 7():. PubMed ID: 29741478
[TBL] [Abstract][Full Text] [Related]
36. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.
Yoshida K; Toden S; Ravindranathan P; Han H; Goel A
Carcinogenesis; 2017 Oct; 38(10):1036-1046. PubMed ID: 29048549
[TBL] [Abstract][Full Text] [Related]
37. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
Ajiro M; Tang S; Doorbar J; Zheng ZM
J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
[TBL] [Abstract][Full Text] [Related]
38. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.
Calabretta S; Bielli P; Passacantilli I; Pilozzi E; Fendrich V; Capurso G; Fave GD; Sette C
Oncogene; 2016 Apr; 35(16):2031-9. PubMed ID: 26234680
[TBL] [Abstract][Full Text] [Related]
39. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.
Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E
Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021
[TBL] [Abstract][Full Text] [Related]
40. Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone.
Buoso E; Galasso M; Ronfani M; Serafini MM; Lanni C; Corsini E; Racchi M
Pharmacol Res; 2017 Jun; 120():180-187. PubMed ID: 28373129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
